These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 2043283)
1. A comparative review of the adverse effects of treatments for hyperlipidaemia. Steiner A; Weisser B; Vetter W Drug Saf; 1991; 6(2):118-30. PubMed ID: 2043283 [TBL] [Abstract][Full Text] [Related]
2. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias. Yee HS; Fong NT Ann Pharmacother; 1998 Oct; 32(10):1030-43. PubMed ID: 9793596 [TBL] [Abstract][Full Text] [Related]
3. Comparison of six pharmacologic regimens for hypercholesterolemia. Hoeg JM; Maher MB; Bailey KR; Brewer HB Am J Cardiol; 1987 Apr; 59(8):812-5. PubMed ID: 3644588 [TBL] [Abstract][Full Text] [Related]
4. Choosing the right lipid-regulating agent. A guide to selection. Farmer JA; Gotto AM Drugs; 1996 Nov; 52(5):649-61. PubMed ID: 9118815 [TBL] [Abstract][Full Text] [Related]
5. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III. JAMA; 1988 Jul; 260(3):359-66. PubMed ID: 2898027 [TBL] [Abstract][Full Text] [Related]
6. Niacin-ER and lovastatin treatment of hypercholesterolemia and mixed dyslipidemia. Yim BT; Chong PH Ann Pharmacother; 2003 Jan; 37(1):106-15. PubMed ID: 12503944 [TBL] [Abstract][Full Text] [Related]
7. Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis. Schiel R; Bambauer R; Müller UA Int J Artif Organs; 1995 Dec; 18(12):786-93. PubMed ID: 8964646 [TBL] [Abstract][Full Text] [Related]
8. An overview of lipid-lowering drugs. Illingworth DR Drugs; 1988; 36 Suppl 3():63-71. PubMed ID: 3076124 [TBL] [Abstract][Full Text] [Related]
9. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin. Maher VM; Thompson GR Q J Med; 1990 Feb; 74(274):165-75. PubMed ID: 2111917 [TBL] [Abstract][Full Text] [Related]
10. Comparison between low-dose simvastatin and cholestyramine in moderately severe hypercholesterolemia. Deslypere JP Acta Cardiol; 1989; 44(5):379-88. PubMed ID: 2690545 [TBL] [Abstract][Full Text] [Related]
11. Lipid-lowering drugs. Med Lett Drugs Ther; 1975 Jun; 17(12):49-50. PubMed ID: 1128443 [No Abstract] [Full Text] [Related]
12. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Hsu I; Spinler SA; Johnson NE Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093 [TBL] [Abstract][Full Text] [Related]
13. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs. Illingworth DR; Bacon S Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189 [TBL] [Abstract][Full Text] [Related]
14. Niacin as a component of combination therapy for dyslipidemia. Miller M Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785 [TBL] [Abstract][Full Text] [Related]
15. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I. Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804 [TBL] [Abstract][Full Text] [Related]
16. Lipid-lowering drugs. Med Lett Drugs Ther; 2019 Feb; 61(1565):17-24. PubMed ID: 30845106 [No Abstract] [Full Text] [Related]
17. Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia. Plosker GL; Wagstaff AJ Drugs; 1996 Mar; 51(3):433-59. PubMed ID: 8882381 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic use of lovastatin in the treatment of hypercholesterolemia. Illingworth DR Clin Ther; 1994; 16(1):2-26; discussion 1. PubMed ID: 8205598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]